Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Small Cell Lung Carcinoma × Vincristine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 52 Lymphoma, Large B-Cell, Diffuse 37 Precursor Cell Lymphoblastic Leukemia-Lymphoma 36 Lymphoma, Follicular 30 Leukemia 27 Lymphoma, Non-Hodgkin 24 Hodgkin Disease 18 Burkitt Lymphoma 18 Neuroblastoma 12 Central Nervous System Neoplasms 12 Lymphoma, Large-Cell, Immunoblastic 11 Sarcoma 9 Multiple Myeloma 9 Rhabdomyosarcoma 8 Lymphoma, Mantle-Cell 8 Oligodendroglioma 6 Lymphoma, T-Cell, Peripheral 6 Lymphoma, Large-Cell, Anaplastic 6 Lymphoma, B-Cell, Marginal Zone 6 Brain Neoplasms 5 Astrocytoma 5 Wilms Tumor 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Neuroectodermal Tumors, Primitive, Peripheral 4 Neoplasms, Plasma Cell 4 Neoplasms 4 Medulloblastoma 4 Malignant mesenchymal tumor 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Hepatoblastoma 4

Interventions

Etoposide 30 Carboplatin 28 Cisplatin 20 Topotecan 19 atezolizumab 9 durvalumab 7 PM 01183 6 Irinotecan 5 amrubicin 4 AMG 757 4 rovalpituzumab tesirine 3 PE regimen 3 Dexamethasone 3 tremelimumab 2 pembrolizumab 2 etoposide phosphate 2 apatinib 2 Vitamin E 2 Tiragolumab 2 RRx-001 2 Magnetic Resonance Spectroscopy 2 trilaciclib 1 toripalimab 1 tislelizumab 1 racotumomab 1 olaparib 1 obatoclax 1 marimastat 1 isophosphamide mustard 1 irinotecan sucrosofate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02566993 2021-10-28

ATLANTIS

PharmaMar

Phase 3 Completed

613 enrolled 46 charts

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡